Home / Industry Reports / Healthcare Market Research
Sort By: Title Date Price

Mens Health - Changing Male Attitudes to Health to Improve Prognosis and Outcomes

Men’s health refers to conditions that specifically affect males, or those that are not gender-specific but have different outcomes in men. Although still dominated by cardiovascular disease, men’s health is increasingly focusing on other conditions and the wellness of the man overall.

$2995 Read More

Global Medical Robotics Market by Country (United States, Canada, India, China, Japan, United Kingdom), Company Profiles, Share, Trends, Analysis, Size, Opportunities, Segmentation and Forecast 2015 – 2021

Healthcare robotics is a nascent but growing market with huge scope in the future. The complex and critical surgeries are being performed through robotic technologies such as minimally invasive surgeries. Such technique enables surgeons to perform various critical surgeries such as the prostate cancer, brain tumor, artery bypass, valve repair and replacement, arterial fibrillation amongst others.

$4000 Read More

Womens Health - Assessing the Need for a Targeted and Specialized Approach

Many of the diseases and conditions that affect mainly women are interlinked with similar root causes; however, placing all of the pieces of the puzzle together to ensure a cohesive management strategy remains a challenge. Women’s Health is a collection of multi-factorial conditions and diseases that solely affect or are more prevalent in females.

$2995 Read More

Portable Oxygen Concentrators: Market Shares, Strategy,and Forecasts, Worldwide, 2015 to 2021

WinterGreen Research announces that it has published a new study Portable Oxygen Concentrators:  Market Shares, Strategy, and Forecasts, Worldwide, 2015 to 2021.  The 2015 study has 458 pages, 150 tables and figures.  Worldwide markets are poised to achieve continuing growth.  Portable oxygen concentrators support lifestyle for oxygen users.  

$4000 Read More

Oxygen Concentrator Market, Shares, Strategies and Forecasts, Worldwide, 2013-2019

WinterGreen Research announces that it has published a new study Oxygen Concentrator Market, Shares, Strategies and Forecasts, Worldwide, 2013-2019. The 2013 study has 572 pages, 241 tables and figures. Worldwide markets are poised to achieve continuing growth as the aging population worldwide needs homecare oxygen treatment. Older people develop COPD and other respiratory conditions where oxygen is able to improve the quality of the life in a dramatic manner. Portable devices have become affordable and support a mobile lifestyle even while on oxygen.

$4000 Read More

Healthcare Decision Support and IBM Watson Market, Shares, Strategies and Forecasts, Worldwide, 2013 to 2019

WinterGreen Research announces that it has published a new study Healthcare Decision Support and IBM Watson Market, Shares, Strategies and Forecasts, Worldwide, 2013 to 2019. The 2013 study has 281 pages, 87 tables and figures. Worldwide healthcare cognitive computing markets are poised to achieve continuing growth as the healthcare delivery system responds to new products. Growth is achieved in response to changing technology, better analytics, and new information systems that leverage natural language, and changing market conditions.

$4000 Read More

Telemedicine and M-Health Convergence Market, Shares, Strategies and Forecasts, Worldwide, 2013 to 2019

WinterGreen Research announces that it has published a new study Telemedicine and M-Health Convergence Market, Shares, Strategies and Forecasts, Worldwide, 2013 to 2019. The 2013 study has 879 pages, 299 tables and figures. Worldwide markets are poised to achieve significant growth as the telemedicine systems merge with the smart phone systems of engagement to provide a way to improve clinical care delivery to patients with chronic disease, decreasing hospitalizations and visits to the emergency room. There is a convergence of telemedicine and m-health as the patients become more responsible for their own care delivery and their own health Clinical telemedicine services converge with m-health systems of engagement to lower cost of care and improve quality of care. Tele-medicine and M-Health Market Convergence driving forces relate to an overall trend toward ordinary people taking more responsibility for their own health. This trend has been more prevalent for women in the past 100 years than for men because women used to die very young and they had to learn how to keep themselves healthy. Women have been able to reverse this trend of dying young and to live longer than men in the past 40 years, illustrating that paying attention to health is important.

$4000 Read More

Push to Talk Telemedicine and M-Health Convergence Market, Shares, Strategies and Forecasts, Worldwide, 2013 to 2019

WinterGreen Research announces that it has published a new study Push to Talk Telemedicine and M-Health Convergence Market, Shares, Strategies and Forecasts, Worldwide, 2013 to 2019. The 2013 study has 791 pages, 278 tables and figures. Worldwide markets are poised to achieve significant growth as the push to talk is used inside telemedicine systems and m-health initiatives as a way to implement ruggedized handset communications for all clinicians.

$4000 Read More

Global Biochips Markets by Country (United States, Canada, India, China, Japan, United Kingdom), Company Profiles, Share, Trends, Analysis, Opportunities, Segmentation and Forecast 2015 – 2021

The global market for Biochips is expected to grow at an annual growth rate (CAGR) of approximately 18% (2015-2021). A Biochip is a collection of miniaturized test sites (microarrays) arranged on a solid substrate that can perform hundreds or thousands of simultaneous biochemical reactions in order to achieve higher throughput and speed. Biochips help researchers to quickly see large number of biological analytics and are used in a range of research applications within the biotechnology sector, including pharmaceuticals, proteomics and genomics.

$4000 Read More

Global Dialysis Market Report: 2015 Edition

Dialysis is the artificial process of eliminating waste and unwanted water from the blood. It is carried out by using a special fluid called dialysate, a mixture of pure water and chemicals, is carefully controlled to pull wastes out of your blood without removing substances your body needs. There are two types of dialysis: hemodialysis and peritoneal dialysis. Hemodialysis removes wastes and water by circulating blood outside the body through an external filter, called a dialyzer and in peritoneal dialysis, wastes and water are removed from the blood inside the body using the peritoneum as a natural semipermeable membrane. End stage renal disease (ESRD) is the last stage of chronic kidney disease.

US Pharmacy Benefit Management (PBM) Industry Report: 2014 Edition

In the US, Pharmacy Benefit Management (PBM) deals with the management of prescription drug programs. It acts as an intermediary between health plans, drug companies, retail pharmacies and patients. Initially, PBMs used to process pharmaceutical claims for health plans. But nowadays in addition to this, PBMs have created more significant ‘pharmacy benefit’ by providing a system for reimbursement of drug claims, processing and cost control. The US prescription volume and pharmaceutical sales has witnessed an exceptional growth over the past few years and the same pattern is likely to continue in the near future.

Global Knee & Hip Market Report: 2014 Edition

The knee and hip joints are the largest joints in the human body. Any dysfunction in any of these joints can cause chronic disorders. Both these joints are large and complex and thus, they are frequently affected by injuries caused in the event of sports activities, accidents, or simply due to aging. Further, conditions like arthritis and bursitis may also cause chronic pain in these joints. Advancing medical technology has brought significant development to enable smooth functioning of joints and to provide them with strength and stability, which, is eventually targeted at providing them with a much better degree of movement. These technological advancements have made related surgeries a more viable option for patients.

Global Diaper Market Report: 2014 Edition

The word “Hygiene” has come from the name of the Greek goddess of health, Hygieia. Hygiene is an age old concept associated with the field of medicine, personal and professional care practices and involves daily routine. Depending upon a number of parameters, hygiene can be categorized into types such as hand hygiene, respiratory hygiene, food hygiene, laundry hygiene, medical hygiene at home, personal hygiene, excessive body hygiene, culinary hygiene and personal hygiene services. In the present context, the hygiene market is covered in terms of baby diapers and adult incontinence products.

Sofosbuvir - Key patent, SPC, and data exclusivity expiry (44 country coverage)

Pipeline Selector helps you avoid hours of painstaking research by quickly providing you with an accurate snapshot of a single INN, including key patents, extensions and data exclusivity expiry for 44 countries (7 country coverage also available), regulatory issues and key players. This Pipeline Selector report covers Sofosbuvir Sofosbuvir indications: Treatment of chronic hepatitis C virus optionally in combination with Ledipasvir and/or Ribavirin, or Ribavirin and Peginterferon alpha 2 Sofosbuvir innovator:

$1300 Read More

Pirfenidone - Key patent, SPC, and data exclusivity expiry (44 country coverage)

Pipeline Selector helps you avoid hours of painstaking research by quickly providing you with an accurate snapshot of a single INN, including key patents, extensions and data exclusivity expiry for 44 countries (7 country coverage also available), regulatory issues and key players. This Pipeline Selector report covers Pirfenidone Pirfenidone indications: Treatment of idiopathic pulmonary fibrosis Pirfenidone innovator: Intermune (Esbriet) Examples of information found in this online report include:

$1300 Read More

Regadenoson - Key patent, SPC, and data exclusivity expiry (44 country coverage)

Pipeline Selector helps you avoid hours of painstaking research by quickly providing you with an accurate snapshot of a single INN, including key patents, extensions and data exclusivity expiry for 44 countries (7 country coverage also available), regulatory issues and key players. This Pipeline Selector report covers Regadenoson Regadenoson indications: Diagnostic aid as a pharmacological stress agent for radionuclide myocardial perfusion imaging in patients unable to undergo adequate exercise stress Regadenoson innovator: Astellas (Lexiscan); Gilead (Rapiscan) Examples of information found in this online report include:

$1300 Read More

Linaclotide - Key patent, SPC, and data exclusivity expiry (44 country coverage)

Pipeline Selector helps you avoid hours of painstaking research by quickly providing you with an accurate snapshot of a single INN, including key patents, extensions and data exclusivity expiry for 44 countries (7 country coverage also available), regulatory issues and key players. This Pipeline Selector report covers Linaclotide Linaclotide indications: Treatment of irritable bowel syndrome with constipation and chronic idiopathic constipation Linaclotide innovator:

$1300 Read More

Teriflunomide - Key patent, SPC, and data exclusivity expiry (44 country coverage)

Pipeline Selector helps you avoid hours of painstaking research by quickly providing you with an accurate snapshot of a single INN, including key patents, extensions and data exclusivity expiry for 44 countries (7 country coverage also available), regulatory issues and key players. This Pipeline Selector report covers Teriflunomide Teriflunomide indications:

$1300 Read More

Ponesimod - Key patent, SPC, and data exclusivity expiry (44 country coverage)

Pipeline Selector helps you avoid hours of painstaking research by quickly providing you with an accurate snapshot of a single INN, including key patents, extensions and data exclusivity expiry for 44 countries (7 country coverage also available), regulatory issues and key players. This Pipeline Selector report covers Ponesimod Ponesimod indications: Treatment of relapsing-remitting multiple sclerosis Ponesimod innovator: Actelion Examples of information found in this online report include:

$1300 Read More

Siponimod - Key patent, SPC, and data exclusivity expiry (44 country coverage)

Pipeline Selector helps you avoid hours of painstaking research by quickly providing you with an accurate snapshot of a single INN, including key patents, extensions and data exclusivity expiry for 44 countries (7 country coverage also available), regulatory issues and key players. This Pipeline Selector report covers Siponimod Siponimod indications: Treatment of relapse remitting and secondary progressive multiple sclerosis Siponimod innovator:

$1300 Read More

Sofosbuvir - Comprehensive patent search

Eliminate unnecessary risk with the industry benchmark in comprehensive patent information. Pipeline Developer is a regularly updated, professional patent search performed by our expert team, which not only identifies relevant patents, but delivers categorisation and interpretation, all delivered by a convenient online interface.  The Pipeline Developer report covers Sofosbuvir Sofosbuvir indications: Treatment of chronic hepatitis C virus optionally in combination with Ledipasvir and/or Ribavirin, or Ribavirin and Peginterferon alpha 2 Sofosbuvir innovator:

$7500 Read More

Pirfenidone - Comprehensive patent search

Eliminate unnecessary risk with the industry benchmark in comprehensive patent information. Pipeline Developer is a regularly updated, professional patent search performed by our expert team, which not only identifies relevant patents, but delivers categorisation and interpretation, all delivered by a convenient online interface.  The Pipeline Developer report covers Pirfenidone Pirfenidone indications: Treatment of idiopathic pulmonary fibrosis Pirfenidone innovator: Intermune (Esbriet) Imagine having your own team of pharmaceutical patent experts, at a fraction of the cost and without the wait. 

$7500 Read More

Regadenoson - Comprehensive patent search

Eliminate unnecessary risk with the industry benchmark in comprehensive patent information. Pipeline Developer is a regularly updated, professional patent search performed by our expert team, which not only identifies relevant patents, but delivers categorisation and interpretation, all delivered by a convenient online interface.  The Pipeline Developer report covers Regadenoson Regadenoson indications: Diagnostic aid as a pharmacological stress agent for radionuclide myocardial perfusion imaging in patients unable to undergo adequate exercise stress Regadenoson innovator:

$7500 Read More

Linaclotide - Comprehensive patent search

Eliminate unnecessary risk with the industry benchmark in comprehensive patent information. Pipeline Developer is a regularly updated, professional patent search performed by our expert team, which not only identifies relevant patents, but delivers categorisation and interpretation, all delivered by a convenient online interface.  The Pipeline Developer report covers Linaclotide Linaclotide indications:

$7500 Read More

Teriflunomide - Comprehensive patent search

Eliminate unnecessary risk with the industry benchmark in comprehensive patent information. Pipeline Developer is a regularly updated, professional patent search performed by our expert team, which not only identifies relevant patents, but delivers categorisation and interpretation, all delivered by a convenient online interface.  The Pipeline Developer report covers Teriflunomide Teriflunomide indications: Treatment of relapsing multiple sclerosis Teriflunomide innovator: Sanofi (Aubagio); Genzyme (Aubagio) Imagine having your own team of pharmaceutical patent experts, at a fraction of the cost and without the wait. 

$7500 Read More

Ponesimod - Comprehensive patent search

Eliminate unnecessary risk with the industry benchmark in comprehensive patent information. Pipeline Developer is a regularly updated, professional patent search performed by our expert team, which not only identifies relevant patents, but delivers categorisation and interpretation, all delivered by a convenient online interface.  The Pipeline Developer report covers Ponesimod Ponesimod indications: Treatment of relapsing-remitting multiple sclerosis Ponesimod innovator: Actelion Imagine having your own team of pharmaceutical patent experts, at a fraction of the cost and without the wait. 

$7500 Read More

Siponimod - Comprehensive patent search

Eliminate unnecessary risk with the industry benchmark in comprehensive patent information. Pipeline Developer is a regularly updated, professional patent search performed by our expert team, which not only identifies relevant patents, but delivers categorisation and interpretation, all delivered by a convenient online interface.  The Pipeline Developer report covers Siponimod Siponimod indications: Treatment of relapse remitting and secondary progressive multiple sclerosis Siponimod innovator:

$7500 Read More

Laquinimod - Comprehensive patent search

Eliminate unnecessary risk with the industry benchmark in comprehensive patent information. Pipeline Developer is a regularly updated, professional patent search performed by our expert team, which not only identifies relevant patents, but delivers categorisation and interpretation, all delivered by a convenient online interface.  The Pipeline Developer report covers Laquinimod Laquinimod indications: Treatment of relapse remitting multiple sclerosis;

$7500 Read More

Afatinib - Comprehensive patent search

Eliminate unnecessary risk with the industry benchmark in comprehensive patent information. Pipeline Developer is a regularly updated, professional patent search performed by our expert team, which not only identifies relevant patents, but delivers categorisation and interpretation, all delivered by a convenient online interface.  The Pipeline Developer report covers Afatinib Afatinib indications: Treatment of locally advanced or metastasic non-small cell lung carcinoma with an epidermal growth factor receptor mutation, optionally in combination with Paclitaxel and/or Loperamide;

$7500 Read More

Cobicistat - Comprehensive patent search

Eliminate unnecessary risk with the industry benchmark in comprehensive patent information. Pipeline Developer is a regularly updated, professional patent search performed by our expert team, which not only identifies relevant patents, but delivers categorisation and interpretation, all delivered by a convenient online interface.  The Pipeline Developer report covers Cobicistat Cobicistat indications: Treatment of HIV-1 infection in antiretroviral treatment-naive patients, in combination with Elvitegravir, Emtricitabine and Tenofovir Cobicistat innovator:

$6200 Read More

Regorafenib - Comprehensive patent search

Eliminate unnecessary risk with the industry benchmark in comprehensive patent information. Pipeline Developer is a regularly updated, professional patent search performed by our expert team, which not only identifies relevant patents, but delivers categorisation and interpretation, all delivered by a convenient online interface.  The Pipeline Developer report covers Regorafenib Regorafenib indications: Treatment of metastatic colorectal cancer Regorafenib innovator: Bayer (Stivarga) Imagine having your own team of pharmaceutical patent experts, at a fraction of the cost and without the wait. 

$7500 Read More

Alogliptin - Comprehensive patent search

Eliminate unnecessary risk with the industry benchmark in comprehensive patent information. Pipeline Developer is a regularly updated, professional patent search performed by our expert team, which not only identifies relevant patents, but delivers categorisation and interpretation, all delivered by a convenient online interface.  The Pipeline Developer report covers Alogliptin Alogliptin indications: Glycaemic control in type 2 diabetes mellitus, optionally in combination with Metformin hydrochloride, thiazolinediones and/or sulfonylureas, or with Insulin optionally in combination with Metformin hydrochloride Alogliptin innovator:

$7500 Read More

Ingenol Mebutate - Comprehensive patent search

Eliminate unnecessary risk with the industry benchmark in comprehensive patent information. Pipeline Developer is a regularly updated, professional patent search performed by our expert team, which not only identifies relevant patents, but delivers categorisation and interpretation, all delivered by a convenient online interface.  The Pipeline Developer report covers Ingenol Mebutate Ingenol Mebutate indications: Cutaneous treatment of non-hyperkeratotic, non-hypertrophic actinic keratosis in adults Ingenol Mebutate innovator: Leo Pharma (Picato) Imagine having your own team of pharmaceutical patent experts

$6200 Read More

China Aged Care Industry Report, 2014-2017

According to the UN standard (the elderly people aged over 60 accounting for 10% of total population or the elderly people over age 65 occupying 7% of total population in one region), China entered the aging society early in 1999. By the end of 2014, China’s population aged over 60 reached 212 million, making up 15.3% of total population, and the people aged 65 and above hit 138.1 million, or 10.1% of total population.

$2500 Read More

Competitor Analysis: Antibody-Drug Conjugates (ADC)

Product description The present Competitive Intelligence Report about Antibody-Drug Conjugates (ADC) / Immunoconjugates provides a competitor evaluation in the field of tumor targeting antibodies conjugated via a linker with a drug payload for treatment of cancer as of April 2013. Purchase of the downloadable pdf report includes a 6-month online access to the data of the report and any updates since the publication date. Credentials to access the database will be sent by e-mail and allow online work with the project data to print or export an individual report. T

Competitor Analysis: Toll-Like Receptor (TLR) Agonists & Antagonists

Toll-Like Receptor (TLR) Agonists & Antagonists Product description The Competitive Intelligence Report Toll-Like Receptor (TLR) Agonists & Antagonists provides a competitor analysis in the development pipeline of novel small molecules, proteins, DNA, RNA and vaccines targeting the toll-like receptors (TLR) for treatment or prevention of cancer, infectious diseases, sepsis and allergy as of October 2011. Purchase of the downloadable pdf report includes a 6-month online access to the data of the report and any updates since the publication date.

Glucagon-Like Peptide-1 (GLP-1) Receptor Agonists - A Target Pipeline and Stakeholder Analysis 2012

Glucagon-Like Peptide-1 (GLP-1) Receptor Agonists - A Target Pipeline and Stakeholder Analysis 2012 This report “ Glucagon-Like Peptide-1 (GLP-1) Receptor Agonists - A Target Pipeline and Stakeholder Analysis 2012 ” published in March 2012 provides a compilation of business, commercial, clinical and scientific information about GLP-1 receptor agonists. A comprehensive analysis of the state of the art and key trends guides the reader through this emerging antidiabetic drug class. Scientific and technological approaches as well as molecules in the target pipeline of GLP-1 receptor agonists are described and assessed.

$2524 Read More

Competitor Analysis: Anti-Infective Antibodies

Competitor Analysis: Anti-Infective Antibodies Product description The present Competitive Intelligence Report about Anti-Infective Antibodies provides a competitor evaluation in the field of recombinant monoclonal and polyclonal antibodies and human plasma-derived immunoglobulins and hyperimmunes for post-exposure prophylaxis and treatment of infectious diseases as of November 2011. Purchase of the downloadable pdf report includes a 6-month online access to the data of the report and any updates since the publication date.

$1029 Read More

Competitor Analysis: Targeted Therapy of Hepatitis C

The present Competitive Intelligence Report about Targeted Therapy of Hepatitis C provides a competitor evaluation in the field of specifically targeted antiviral therapeutics for hepatitis C (STAT-C) as of August 2011. Purchase of the downloadable pdf report includes a 6-month online access to the data of the report and any updates since the publication date. Credentials to access the database will be sent by e-mail and allow online work with the project data to print or export an individual report. Most hepatitis C virus (HCV) infected individuals seeking treatment are chronically infected.

Occupational Health - United Kingdom - June 2015

Many businesses still view occupational health as an uncertain investment in improving business performance, but the case for investing in OH has never been greater. Absenteeism costs the UK economy up to £31 billion a year, with the average UK worker taking an estimated 4.5 days off sick annually according to LFS data.

$2422 Read More

Consumer Trends and Market Outlook for the Hand Care Market in Russia to 2016

Synopsis The report provides in-depth market analysis, information and insights into the Russian hand care market, including: Hand care market analysis by consumer segmentation, group value and trend influence Consumption analysis by volume and segment in the Russian hand care market Russian skin care market analysis by value and impact Executive summary Consumer Trends and Market Outlook for the Hand Care Market in Russia to 2016 is the result of Canadean /BRICdata’s extensive market research into the Hand Care market covering skincare consumption and consumer trends in Russia.

$1950 Read More

Consumer Trends and Market Outlook for the Hand Care Market in Brazil to 2016

Synopsis The report provides in-depth market analysis, information and insights into the Brazilian hand care market, including: Hand care market analysis by consumer segmentation, group value and trend influence Consumption analysis by volume and segment in the Brazilian hand care market Brazilian skin care market analysis by value and impact Executive summary Consumer Trends and Market Outlook for the Hand Care Market in Brazil to 2016 is the result of Canadean /BRICdata’s extensive market research into the Hand Care market covering skincare consumption and consumer trends in Brazil.

$1950 Read More

Trends in Health and Wellness - China - May 2015

Chinese consumers’ consciousness towards health and wellness is rising. The good news for brands and companies is that there are great opportunities between consumer demands and current products in the market. And products can become more attractive by leveraging better ingredients and product packaging.

$3990 Read More

Assessment of the Molecular Diagnostic Market for 38 NA Tests in Germany, 2011

Update of the 2009 started comprehensive European market assessment for molecular diagnostics from the end user perspective. Hospital and private laboratories have been surveyed to collect information on NA tests, test volumes, used platforms and technologies (amplification & detection) and reagents.

$7500 Read More

Assessment of the Molecular Diagnostic Market for 38 NA Tests in France, 2011

 Update of the 2009 started comprehensive European market assessment for molecular diagnostics from the end user perspective. Hospital and private laboratories have been surveyed to collect information on NA tests, test volumes, used platforms and technologies (amplification & detection) and reagents.

$7500 Read More

Assessment of the Molecular Diagnostic Market for 38 NA Tests in UK, 2011

Update of the 2009 started comprehensive European market assessment for molecular diagnostics from the end user perspective. Hospital and private laboratories have been surveyed to collect information on NA tests, test volumes, used platforms and technologies (amplification & detection) and reagents. For data reliability and accurate projections at segment level a 3 step methodology has been applied:

$7500 Read More

Assessment of the Molecular Diagnostic Market for 38 NA Tests in Italy, 2011

Update of the 2009 started comprehensive European market assessment for molecular diagnostics from the end user perspective. Hospital and private laboratories have been surveyed to collect information on NA tests, test volumes, used platforms and technologies (amplification & detection) and reagents.

$7500 Read More

Assessment of the Molecular Diagnostic Market for 38 NA Tests in Spain, 2011

Update of the 2009 started comprehensive European market assessment for molecular diagnostics from the end user perspective. Hospital and private laboratories have been surveyed to collect information on NA tests, test volumes, used platforms and technologies (amplification & detection) and reagents.

$7500 Read More

Continuous Hospital Imaging Market Census, Germany 2010 and Outlook to 2015

This is the most comprehensive European market report on the development of installed base of radiology modality types (General Radiology, Mammography, R&F, Angiography, CT, MRI,) and radiology IT systems (PACS, Teleradiology, Advanced Visualisation, Imaging Data Center, Computer Aided Detection) in European hospitals.

$7950 Read More

Continuous Hospital Imaging Market Census France 2010 and Outlook to 2015

This is the most comprehensive European market report on the installed base of radiology modality types (General Radiology, Mammography, R&F, Angiography, CT, MRI,) and radiology IT systems (PACS, Teleradiology, Advanced Visualisation, Imaging Data Center, Computer Aided Detection) in European hospitals.

$7950 Read More

Continuous Hospital Imaging Market Census, UK 2010 and Outlook to 2015

This is the most comprehensive European market report on the installed base of radiology modality types (General Radiology, Mammography, R&F, Angiography, CT, MRI,) and radiology IT systems (PACS, Teleradiology, Advanced Visualisation, Imaging Data Center, Computer Aided Detection) in European hospitals.

$7950 Read More

Continuous Hospital Imaging Market Census, Italy 2010 and Outlook to 2015

This is the most comprehensive European market report on the installed base of radiology modality types (General Radiology, Mammography, R&F, Angiography, CT, MRI,) and radiology IT systems (PACS, Teleradiology, Advanced Visualisation, Imaging Data Center, Computer Aided Detection) in European hospitals. Hospitals are periodically surveyed to collect information on installed systems, room configuration, manufacturer of the system, year of installation, lifespan, investment plans, number of examinations and budgets

$7950 Read More

Continuous Hospital Imaging Market Census, Spain 2010 and Outlook to 2015

This is the most comprehensive European market report on the installed base of radiology modality types (General Radiology, Mammography, R&F, Angiography, CT, MRI,) and radiology IT systems (PACS, Teleradiology, Advanced Visualisation, Imaging Data Center, Computer Aided Detection) in European hospitals.

$7950 Read More

Continuous Hospital General Radiology Market Census , Europe 2010 and Outlook to 2015

This is the most comprehensive European market report on the installed base of General Radiology and radiology IT systems (PACS) in European hospitals. Hospitals are periodically surveyed to collect information on installed systems, room configuration, manufacturer of the system, year of installation, lifespan, investment plans, number of examinations and budgets

$9900 Read More

Continuous Hospital General Radiology Market Census , Germany 2010 and Outlook to 2015

This is the most comprehensive European market report on the installed base of General Radiology and radiology IT systems (PACS) in European hospitals. Hospitals are periodically surveyed to collect information on installed systems, room configuration, manufacturer of the system, year of installation, lifespan, investment plans, number of examinations and budgets

$2250 Read More

Continuous Hospital General Radiology Market Census , France 2010 and Outlook to 2015

This is the most comprehensive European market report on the installed base of General Radiology and radiology IT systems (PACS) in European hospitals. Hospitals are periodically surveyed to collect information on installed systems, room configuration, manufacturer of the system, year of installation, lifespan, investment plans, number of examinations and budgets

$2250 Read More

Continuous Hospital General Radiology Market Census , UK 2010 and Outlook to 2015

This is the most comprehensive European market report on the installed base of General Radiology and radiology IT systems (PACS) in European hospitals. Hospitals are periodically surveyed to collect information on installed systems, room configuration, manufacturer of the system, year of installation, lifespan, investment plans, number of examinations and budgets

$2250 Read More

Continuous Hospital General Radiology Market Census , Italy 2010 and Outlook to 2015

 This is the most comprehensive European market report on the installed base of General Radiology and radiology IT systems (PACS) in European hospitals. Hospitals are periodically surveyed to collect information on installed systems, room configuration, manufacturer of the system, year of installation, lifespan, investment plans, number of examinations and budgets

$2250 Read More

Continuous Hospital General Radiology Market Census , Spain 2010 and Outlook to 2015

This is the most comprehensive European market report on the installed base of General Radiology and radiology IT systems (PACS) in European hospitals. Hospitals are periodically surveyed to collect information on installed systems, room configuration, manufacturer of the system, year of installation, lifespan, investment plans, number of examinations and budgets

$2250 Read More

Continuous Hospital Mammography Market Census, Europe 2010 and Outlook to 2015

This is the most comprehensive European market report on the installed base of radiology modality types (General Radiology, Mammography, R&F, Angiography, CT, MRI,) and radiology IT systems (PACS, Teleradiology, Advanced Visualisation, Imaging Data Center, Computer Aided Detection) in European hospitals. Hospitals are periodically surveyed to collect information on installed systems, room configuration, manufacturer of the system, year of installation, lifespan, investment plans, number of examinations and budgets

$7950 Read More

Continuous Hospital Mammography Market Census, Germany 2010 and Outlook to 2015

This is the most comprehensive European market report on the installed base of radiology modality types (General Radiology, Mammography, R&F, Angiography, CT, MRI,) and radiology IT systems (PACS, Teleradiology, Advanced Visualisation, Imaging Data Center, Computer Aided Detection) in European hospitals. Hospitals are periodically surveyed to collect information on installed systems, room configuration, manufacturer of the system, year of installation, lifespan, investment plans, number of examinations and budgets

$2000 Read More

Continuous Hospital Mammography Market Census, France 2010 and Outlook to 2015

This is the most comprehensive European market report on the installed base of radiology modality types (General Radiology, Mammography, R&F, Angiography, CT, MRI,) and radiology IT systems (PACS, Teleradiology, Advanced Visualisation, Imaging Data Center, Computer Aided Detection) in European hospitals.

$2000 Read More

Continuous Hospital Mammography Market Census, UK 2010 and Outlook to 2015

This is the most comprehensive European market report on the installed base of radiology modality types (General Radiology, Mammography, R&F, Angiography, CT, MRI,) and radiology IT systems (PACS, Teleradiology, Advanced Visualisation, Imaging Data Center, Computer Aided Detection) in European hospitals.

$2000 Read More

Continuous Hospital Mammography Market Census, Italy 2010 and Outlook to 2015

This is the most comprehensive European market report on the installed base of radiology modality types (General Radiology, Mammography, R&F, Angiography, CT, MRI,) and radiology IT systems (PACS, Teleradiology, Advanced Visualisation, Imaging Data Center, Computer Aided Detection) in European hospitals.

$2000 Read More

Continuous Hospital Mammography Market Census, Spain 2010 and Outlook to 2015

This is the most comprehensive European market report on the installed base of radiology modality types (General Radiology, Mammography, R&F, Angiography, CT, MRI,) and radiology IT systems (PACS, Teleradiology, Advanced Visualisation, Imaging Data Center, Computer Aided Detection) in European hospitals.

$2000 Read More

Continuous Hospital Radiography & Fluoroscopy Market Census, Europe 2010 and Outlook to 2015

This is the most comprehensive European market report on the installed base of radiology modality types (General Radiology, Mammography, R&F, Angiography, CT, MRI,) and radiology IT systems (PACS, Teleradiology, Advanced Visualisation, Imaging Data Center, Computer Aided Detection) in European hospitals.

$7950 Read More

US Market Changes in the Treatment of Advanced Prostate Cancer

Progressively unfolding patient case scenarios were presented to 151 U.S. oncologists in a survey for their open-ended responses providing rich insight into their clinical decisions. Data includes specific treatment choices, factors that influence their decisions, barriers to optimal treatment and confidence in treatment and management of patients.

$2900 Read More

US Market Changes in the Treatment of Non-Hodgkin's Lymphoma

The purpose of this research study is to examine the current and evolving practice patterns of oncologists in managing advanced non-Hodgkins lymphoma. A survey with unfolding patient case scenarios was presented to 158 U.S. oncologists for their open-ended responses to questions concerning their choices of treatment regimens, factors that influenced their decisions, barriers to optimal patient treatment and confidence in treatment and management of patients.

$2900 Read More

US Market Changes in the Treatment of Advanced Melanoma

Progressively unfolding patient case scenarios were presented to 200 U.S. oncologists, who manage patients with advanced melanoma, to understand differences in clinical decisions and the factors that influence those decisions. Data presented includes oncologist treatment regimen choices, factors that influence their decisions, barriers to optimal patient care and confidence in patient treatment. 

$2900 Read More

Continuous Hospital Radiography & Fluoroscopy Market Census, Germany 2010 and Outlook to 2015

This is the most comprehensive European market report on the installed base of radiology modality types (General Radiology, Mammography, R&F, Angiography, CT, MRI,) and radiology IT systems (PACS, Teleradiology, Advanced Visualisation, Imaging Data Center, Computer Aided Detection) in European hospitals. Hospitals are periodically surveyed to collect information on installed systems, room configuration, manufacturer of the system, year of installation, lifespan, investment plans, number of examinations and budgets

$2000 Read More

Continuous Hospital Radiography & Fluoroscopy Market Census, France 2010 and Outlook to 2015

This is the most comprehensive European market report on the installed base of radiology modality types (General Radiology, Mammography, R&F, Angiography, CT, MRI,) and radiology IT systems (PACS, Teleradiology, Advanced Visualisation, Imaging Data Center, Computer Aided Detection) in European hospitals.

$2000 Read More

US Market Changes in the Treatment of Advanced Lung Cancer

The purpose of this study is to examine changes in the market for therapeutics used in the treatment of advanced lung cancer by examining longitudinal practice patterns of oncologists. Progressively unfolding patient case scenarios were presented to 152 U.S. oncologists for their responses to open-ended questions concerning their choices of treatment regimens, factors that influence their decisions, barriers to optimal patient treatment and confidence in treatment and management of patients.

$2900 Read More

Continuous Hospital Radiography & Fluoroscopy Market Census, Italy 2010 and Outlook to 2015

This is the most comprehensive European market report on the installed base of radiology modality types (General Radiology, Mammography, R&F, Angiography, CT, MRI,) and radiology IT systems (PACS, Teleradiology, Advanced Visualisation, Imaging Data Center, Computer Aided Detection) in European hospitals.

$2000 Read More

Continuous Hospital Radiography & Fluoroscopy Market Census, Spain 2010 and Outlook to 2015

This is the most comprehensive European market report on the installed base of radiology modality types (General Radiology, Mammography, R&F, Angiography, CT, MRI,) and radiology IT systems (PACS, Teleradiology, Advanced Visualisation, Imaging Data Center, Computer Aided Detection) in European hospitals.

$2000 Read More

Continuous Hospital Angiography Market Census, Europe 2010 and Outlook to 2015

This is the most comprehensive European market report on the installed base of radiology modality types (General Radiology, Mammography, R&F, Angiography, CT, MRI,) and radiology IT systems (PACS, Teleradiology, Advanced Visualisation, Imaging Data Center, Computer Aided Detection) in European hospitals.

$7950 Read More

Continuous Hospital Angiography Market Census, Germany 2010 and Outlook to 2015

This is the most comprehensive European market report on the installed base of radiology modality types (General Radiology, Mammography, R&F, Angiography, CT, MRI,) and radiology IT systems (PACS, Teleradiology, Advanced Visualisation, Imaging Data Center, Computer Aided Detection) in European hospitals.

$2000 Read More

M2M Market in the South East Asian Region

The Southeast Asian market has special significance for the M2M industry. The region's manufacturing infrastructure is radically changed and human development indices for individual countries compare favorably with the very best in the world. The geographical significance of the region is beyond doubt; as it lies on critical maritime paths.

$5000 Read More

Research Report on Medical Industry in China 2014 - 2018

In China, medical institutions refer to licensed (the Practice License of Medical Institutions) hospitals, health centers, clinics and first-aid stations that diagnose and treat diseases.

$2400 Read More

hERG Screening

This report on hERG Screening presents an in depth analysis of hERG Screening market. The study emphasizes on both technology and product segments of hERG Screening in biotechnology and pharmaceutical application areas. The report provides essential information including market data, segmentation, market size, key trends, M&A, product developments, industry forecasts, corporate intelligence, and other relevant information.

$4150 Read More

Biomarkers

This report on Biomarkers focuses on the different types of biomarkers and their impact on various disease areas such as oncology (prostate, ovarian, breast and lung), neurology (stroke, brain tumor, neurodegenerative diseases), cardiology (coronary heart disease, heart failure, myocardial infarction), infectious diseases (GIT, respiratory tract infections) and other areas including metabolomic turmoil, arthritis, gynecology, oxidative stress, liver disease, pulmonary disease and aging, etc.

$4650 Read More

Metabolomics

This report gives an insight into Metabolomics Technologies - Combined/Integrated Systems, Hardware Systems for metabolic analytics, and Software Systems. Estimations and predictions for the total global Metabolomics Technologies' market are given by geographic regions encompassing United States, Canada, Europe, Asia-Pacific, and Japan. Business profiles of more than 25 major companies are discussed in the report.

$3900 Read More

Angiogenesis Modulators

This report on Angiogenesis Modulators & Therapeutics studies the impact of Inhibitors and Stimulators on various diseases. The study focuses on major angiogenesis inhibitors and their role in diseases such as cancer, cardiology, ophthalmology, and other angiogenesis based diseases including endometriosis and inflammatory diseases.

$4100 Read More

Apoptosis

This report gives an insight into Apoptosis Mechanism, by Molecular Pathways Caspase Activators and Inhibitors, Protease/Proteasome Inhibitors, Bcl-2 Modulators, p53 Modulators and Other.

$4150 Read More

Chiral Chemicals

This report on Chiral Chemicals focuses on the different methods and applications of Chiral Chemicals and their impact. Various Chiral Chemical preparation and separation methods include Traditional, Asymmetric, Biological and Other. Pharmaceuticals, Agrochemicals, Flavors/Fragrances are the different chiral chemical applications discussed.

$4650 Read More

Biological Implants

This report on Biological Implants analyzes the global market for biological implant procedures. The total biological implants market is analyzed by tissue/muscle; origin, and mode of administration at global level and for each of the geographic regions - North America, Europe, Asia-Pacific and Rest of World.

$4150 Read More

Bionanotechnology

This report on Bionanotechnology studies the impact of Nanotechnology in various Biotechnology applications. The study focuses on major Applications including Food, Drug Discovery and Development, Diagnostic Tools and Devices, and Other (Bionanosensors). Estimations and Predictions are also illustrated by geographic regions encompassing North America, Europe, Japan, Asia-Pacific, Israel and Rest of World.

$4650 Read More

Biochips

This report on Biochips studies the impact of Biochips in various applications. The study focuses on major Biochip Types, Applications and Biochips Related Products. The emphasis is also given on major Biochips Types including DNA, Protein, Lab-On-Chip and Other (Cellular chips, Tissue chips, Drug of Abuse Chips , etc.) in various Applications such as Drug Discovery& Development, Genomics, and Clinical Diagnosis and Other (Water and Environmental Testing, Forensics, Identity Testing, etc.).

$4400 Read More

DNA Sequencing

This report presents an in depth analysis of DNA Sequencing market. The study emphasizes on both, the Methods and Instruments/Software of DNA Sequencing in Medical Research, Agriculture & Animal Husbandry and DNA Testing & Forensics application areas.

$4350 Read More

Intravenous Solutions

This market insight report on IV (Intravenous) Solutions is analyzed by Type and Nutrients for each of the geographic regions-North America, Europe, Asia-Pacific and Rest of World. The global IV Solutions market segments includes by Type- Partial Parenteral Nutrition (PPN) & Total Parenteral Nutrition (TPN); by Nutrients-Carbohydrates, Salt and Electrolytes, Minerals and Vitamins and Amino Acids. Estimations and predictions for the total global IV solutions market are given by geographic regions.

$4400 Read More

Prions

This market insight report on Prions gives an insight into the global market for Prion Deactivation technologies, Post Mortem Testing for BSE and Prion Reduction Filters. The Prion related products include BSE detection test Kits, Deactivation/Inactivation technologies, Reagents and Services.

$4600 Read More

Bioimaging

This market insight report on Bioimaging focuses on the different types and modalities of bioimaging and their application in Research and Development and Diagnostics. The study provides global market analysis for bioimaging by Modalities including Ultrasound, CT, MRI, PET, SPECT and other modalities comprising X-Ray, TEM and OCT. The study includes estimations and predictions for the total global bioimaging market.

$4550 Read More

Veterinary Vaccines

This market insight report on Veterinary Vaccines covers the Types of Veterinary Vaccines and the different Species for which Vaccines are present in the market. The Types of Veterinary Vaccines covered include Live Attenuated, Inactivated, Recombinant and Other (Conjugate Vaccines, DNA Vaccines, Toxoids etc). The Species include Bovine, Porcine, Poultry, Canine & Feline, Ovine & Caprine and Other (Equine, Fish, Wild Animals etc.).

$4300 Read More

Stem Cell Research in Cardiology

This market insight report on Stem Cell Research in Cardiology emphasizes on the market for stem cells in Cardiology. The study is segmented by Source (Allogenic and Autogenic) and by Type (Bone Marrow Stem Cells, Embryonic Stem Cells, and Other). Estimations and Predictions for 2005-2020 are graphically illustrated by geographic regions encompassing North America, Europe, Asia-Pacific, and Rest of World.

$4600 Read More

Tissue Sealants

This market insight report on Tissue Sealants provides an in depth analysis of the global Tissue Sealants market including various sources of Sealants and the various applications. The Sources of Tissue Sealants covered include Homologous Sealants, Synthetic Sealants and Autologous Sealants. The applications of Tissue Sealants covered include Odontology, Cardiology, Neurology, Orthopedics and Other (such as Urology, Hepatic, and Dermatology etc.).

$3850 Read More

Insulin Pen Market, Users (Reusable & Prefilled) & Forecast - Worldwide Analysis

In 2013, more than 50 Thousand insulin users opt for an insulin pen. Out of this major percentage of population uses Reusable (Cartridge) insulin pen compared to Prefilled (Disposable) insulin pen. Insulin Pen market for 2013 is in double digit Billion US$ and it is expected to grow by 13% from 2013 to 2018.

$1990 Read More

Malaysia Medical Tourism Analysis & Forecast

Malaysia has emerged as a strong competitor in the global health and medical tourism sector. Given the potential of medical tourism as a foreign exchange earner, the Malaysian government has taken a series of proactive measures to enhance Malaysia as a preferred health tourism destination. Malaysia offers a wide choice of state–of–the–art private medical centers boasting an impressive array of sophisticated diagnosis, therapeutic and in–patient facilities.

$1100 Read More

Cellmid Limited - Product Pipeline Review - 2015

This report provides comprehensive information on the current therapeutic developmental pipeline of Cellmid Limited’s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

$1500 Read More

Global and China Breast Implants Industry 2014 Market Research Report

The report firstly introduced Breast Implants basic information included Breast Implants definition classification application industry chain structure industry overview; international market analysis, China domestic market analysis, Macroeconomic environment and economic situation analysis and influence, Breast Implants industry policy and plan, Breast Implants product specification, manufacturing process, product cost structure etc. then statistics Global and China key manufacturers Breast Implants capacity production cost price profit production value gross margin etc.

$2600 Read More

Global and China Seasonal Influenza Vaccine Industry 2014 Market Research Report

The report firstly introduced Seasonal Influenza Vaccine basic information included Seasonal Influenza Vaccine definition classification application industry chain structure industry overview; international market analysis, China domestic market analysis, Macroeconomic environment and economic situation analysis and influence, Seasonal Influenza Vaccine industry policy and plan, Seasonal Influenza Vaccine product specification, manufacturing process, product cost structure etc. then statistics Global and China key manufacturers Seasonal Influenza Vaccine capacity production cost price profit production value gross margin etc.

$2600 Read More

Global and China Active Prostheses Industry 2014 Market Research Report

The report firstly introduced Active Prostheses basic information included Active Prostheses definition classification application industry chain structure industry overview; international market analysis, China domestic market analysis, Macroeconomic environment and economic situation analysis and influence, Active Prostheses industry policy and plan, Active Prostheses product specification, manufacturing process, product cost structure etc. then statistics Global and China key manufacturers Active Prostheses capacity production cost price profit production value gross margin etc.

$2600 Read More

Healthcare Market Research Reports

Health related diseases and problems have drastically increased with age across the world, and thus, the market demand for healthcare products have elevated along with it. For past few years, the healthcare sector has displayed a significant market growth. Today the healthcare industry accounts for large labor intensive healthcare activities, breakthroughs in medical techniques and patient needs- all of which increases average life expectancy of the population including the standard of living of the people.

The healthcare industry includes two key industrial groups. The first group encompasses the production of healthcare devices and deliverables encompassing healthcare products distributors, healthcare services operators and healthcare service providers. The second group under the healthcare sector include pharmaceuticals products manufacture, research & development, biotechnology products manufacture, marketing of pharmaceuticals products and marketing of biotechnology items.

Most of the persons are attracted to the healthcare sector for its service oriented and personal touch approach. Further, the preference for home healthcare over the hospital settings has increased among the aging population as well as the constantly ill population. Now, it is the home healthcare market and substitute medical treatments that is predicted to grow at a good pace.

Healthcare industry remains one of the fastest growing sectors of the worldwide economy. It poses immeasurable challenges to the private industrial segment as well as policy section in generally every nation of the world. According to market analysts, the global healthcare amenity market is predicted to reach a revenue margin of about three trillion US dollars by the end of year 2015. Industrial sectors of healthcare industry like telehealth, home healthcare and healthcare IT in the market are projected to expand and contribute to the market growth with the developments of this industry.

Market Research Reports of Acute Market Reports provides you detailed information and comprehensive market research analysis of the ongoing market trends, future market trends, competitive landscape of market, technological trends, impact of market forces on business, competitive market dynamics, market strategies, brands in market product positioning in market, product portfolio , market share and business strategies. It also includes financial overview, company overview, market overview, future growth prospects, market growth aspects, business overview of the market and comprehensive information of the factors affecting the growth of the sector. It also includes different kinds of industry analysis represented by graphical tools and pictorial diagrammatic representation of data such as bar charts, pie charts, column charts, tables, spreadsheets and histograms. Our years of proven techniques, market predictions and evaluation of the market helps you in knowing the industrial gravity and helps you in your business growth. It also helps to shape the future of your business in a positive way.